JP7610265B2 - 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法 - Google Patents

大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法 Download PDF

Info

Publication number
JP7610265B2
JP7610265B2 JP2021540745A JP2021540745A JP7610265B2 JP 7610265 B2 JP7610265 B2 JP 7610265B2 JP 2021540745 A JP2021540745 A JP 2021540745A JP 2021540745 A JP2021540745 A JP 2021540745A JP 7610265 B2 JP7610265 B2 JP 7610265B2
Authority
JP
Japan
Prior art keywords
colon cancer
mir
hsa
diagnostic marker
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021540745A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021033605A1 (https=
JPWO2021033605A5 (https=
Inventor
貴也 志村
弘靖 岩崎
洋望 片岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagoya City University
Original Assignee
Nagoya City University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagoya City University filed Critical Nagoya City University
Publication of JPWO2021033605A1 publication Critical patent/JPWO2021033605A1/ja
Publication of JPWO2021033605A5 publication Critical patent/JPWO2021033605A5/ja
Application granted granted Critical
Publication of JP7610265B2 publication Critical patent/JP7610265B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021540745A 2019-08-16 2020-08-12 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法 Active JP7610265B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019149338 2019-08-16
JP2019149338 2019-08-16
PCT/JP2020/030676 WO2021033605A1 (ja) 2019-08-16 2020-08-12 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法

Publications (3)

Publication Number Publication Date
JPWO2021033605A1 JPWO2021033605A1 (https=) 2021-02-25
JPWO2021033605A5 JPWO2021033605A5 (https=) 2022-06-21
JP7610265B2 true JP7610265B2 (ja) 2025-01-08

Family

ID=74660946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540745A Active JP7610265B2 (ja) 2019-08-16 2020-08-12 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法

Country Status (5)

Country Link
US (1) US20220290249A1 (https=)
EP (1) EP4015635A4 (https=)
JP (1) JP7610265B2 (https=)
CN (1) CN114746551A (https=)
WO (1) WO2021033605A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024173418A1 (en) * 2023-02-16 2024-08-22 Infinitum Health, Llc Methods of inhibiting cancer growth and inhibiting viral infections

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143499A1 (en) 2010-05-12 2011-11-17 Tengion, Inc. Bioactive renal cells
US20130137593A1 (en) 2010-04-15 2013-05-30 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
WO2016186987A1 (en) 2015-05-15 2016-11-24 Trustees Of Dartmouth College Biomarker micrornas and method for determining tumor burden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
JP5836397B2 (ja) * 2011-01-13 2015-12-24 インダストリアル テクノロジー リサーチ インスティテュートＩｎｄｕｓｔｒｉａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ 結腸直腸がんの再発予測のためのバイオマーカー
CN118813801A (zh) * 2014-06-13 2024-10-22 东丽株式会社 大肠癌的检测试剂盒或装置以及检测方法
JP7281117B2 (ja) 2018-02-28 2023-05-25 東芝ライテック株式会社 照明器具

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130137593A1 (en) 2010-04-15 2013-05-30 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
WO2011143499A1 (en) 2010-05-12 2011-11-17 Tengion, Inc. Bioactive renal cells
WO2016186987A1 (en) 2015-05-15 2016-11-24 Trustees Of Dartmouth College Biomarker micrornas and method for determining tumor burden

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cell Death and Disease，2015年，Vol.6, e1614，p.1-11
MOLECULAR MEDICINE REPORTS，2018年，Vol.17，p.2991-2997

Also Published As

Publication number Publication date
JPWO2021033605A1 (https=) 2021-02-25
US20220290249A1 (en) 2022-09-15
WO2021033605A1 (ja) 2021-02-25
EP4015635A4 (en) 2023-10-25
CN114746551A (zh) 2022-07-12
EP4015635A1 (en) 2022-06-22

Similar Documents

Publication Publication Date Title
CN111961725B (zh) 胰腺癌的检测试剂盒或装置以及检测方法
JP6989863B2 (ja) 大腸癌の診断方法
JP6770957B2 (ja) 試料中のｐｉｋ３ｃａ突然変異状態を決定する方法
KR101437718B1 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
RU2737449C1 (ru) Система для предсказания прогноза и пользы от вспомогательной химиотерапии для больных раком желудка ii и iii стадии
CN106414774A (zh) 胆道癌的检测试剂盒或装置以及检测方法
CN106662543B (zh) 肺癌患者中的非侵入性基因突变检测
US20200332363A1 (en) Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
CN107208149B (zh) 结直肠癌相关疾病的生物标志物
CN113774131B (zh) 一种用于非小细胞肺癌早期诊断、治疗与预后检测的分子分型标志物及试剂盒
CN114908171A (zh) 人HHIPL2 mRNA在非小细胞肺癌靶向治疗和预后评估中的应用及试剂盒
CN116287258B (zh) 一种新型分子标志物在乳腺癌诊断或预后评估中的应用
EP3478855B1 (en) Use of the expression of specific genes for the prognosis of patients with triple negative breast cancer
JP7610265B2 (ja) 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法
JP6608424B2 (ja) 前癌性結腸直腸ポリープおよび結腸直腸癌を特定するための方法およびキット
JP7345860B2 (ja) 胃癌バイオマーカー及びその用途
JP2021129513A (ja) びまん性肺胞障害型薬剤性間質性肺炎のｍｉＲＮＡ診断バイオマーカー
JP2024035040A (ja) 分析方法、キット及び検出用デバイス
JP5586164B2 (ja) 潰瘍性大腸炎患者の癌化リスクを決定する方法
EP4379064A1 (en) Diagnostic methods and diagnostic assay comprising detection of lncrnas
CN114107487B (zh) 一种可用于诊断脑卒中的产品
US11377699B2 (en) Methods for evaluating head and neck cancers
US20220291220A1 (en) Methods and compositions for detection and treatment of lung cancer
KR101930818B1 (ko) 방광암의 비침습적 진단 방법
US20250298015A1 (en) Diagnostic method of detecting inflammation biomarker(s)

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20220118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220204

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230531

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240718

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241002

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241213

R150 Certificate of patent or registration of utility model

Ref document number: 7610265

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S631 Written request for registration of reclamation of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313631

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350